HEAR FROM PEERS
Peer-to-peer learning hub
Play Video
Novel Genomic Testing: Improving Diagnostic Confidence for Lung Nodules
Hear how Dr. Kurman uses Percepta GSC to stratify the risk of primary lung cancer across all pre-test risk groups to guide patient management when bronchoscopy is inconclusive
Case Studies & Presentations
Percepta GSC resource library
Watch case studies and testimonials from physicians or on-demand videos about Percepta GSC and its clinical utility.
Case studies & testimonials
On-demand presentations
- POSTED ON
- Mar 26, 2021
Percepta GSC and Envisia Classifier Case Study
Dr. Nina Maouelainin shares a case where Percepta GSC up-classified the risk of lung cancer guiding the next intervention step, and Envisia determined a UIP pattern to improve ILD diagnostic confidence, guiding management using a non-invasive bronchoscopy.
- POSTED ON
- Mar 26, 2021
Percepta GSC Up-Classification Case Study
Dr. Andres Yepes shares a clinical case where Percepta GSC up-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, informing the next intervention steps.
- POSTED ON
- Mar 26, 2021
Percepta GSC Down-Classification Case Study
Dr. Andres Yepes shares a case where Percepta GSC down-classified the risk of lung cancer for an intermediate pre-test risk patient with an inconclusive bronchoscopy, saving the patient from an unnecessary invasive procedure.
- POSTED ON
- Mar 26, 2021
Percepta GSC Physician Testimonial
Hear from Dr. Nina Maouelainin on how she integrated Percepta GSC into her clinical practice and the test’s impact on patient management.
- POSTED ON
- Oct 6, 2020
Percepta GSC Clinical Case Review
Dr. Krish Bhadra shares a case where Percepta GSC down-classified the risk and changed patient management.
- POSTED ON
- Dec 20, 2021
Novel Genomic Testing: Improving Diagnostic Confidence for Lung Nodules
Hear how Dr. Kurman uses Percepta GSC to stratify the risk of primary lung cancer across all pre-test risk groups as a guide for patient management when bronchoscopy is inconclusive.
- POSTED ON
- Nov 8, 2021
Percepta GSC Overview and Integration in Clinical Practice
Dr. Chakravarthy Reddy, Associate Professor, University of Utah School of Medicine, shares an overview of the Percepta Genomic Sequencing Classifier to stratify the risk of lung cancer when bronchoscopy is inconclusive and how to integrate this test into clinical practice.
- POSTED ON
- Jun 2, 2021
ASCO 2021 Percepta GSC
In this research, Dr. Sonali Sethi and colleagues assess the potential clinical utility of the Percepta Genomic Sequencing Classifier (GSC) in up-classifying pre-test high risk lung nodules to very high risk (>91%) after a nondiagnostic bronchoscopy.
Stratify the risk of primary lung cancer to guide patient management
Inconclusive bronchoscopy results can lead to uncertainty in next steps and delays in diagnosis. Percepta GSC stratifies the risk of primary lung cancer to guide patient management when bronchoscopy is inconclusive.